Companies want compromise on EU human tissue rules
This article was originally published in Clinica
The European medical devices industry association, EUCOMED, is calling on the European Commission to adopt a measured approach in its regulation of medical devices containing human tissues. It fears an over-stringent approach would damage European industry and place it at a disadvantage compared to companies operating in other markets, such as the US, in a product area where European companies currently have "significant leadership".
You may also be interested in...
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.
A lower first dose boosted the vaccine’s efficacy result, but AstraZeneca has conceded that this has to be proven in a separate trial. In the meantime, the UK government has asked the regulator to assess the vaccine under a special health emergency provision.